RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,557,585 | -16.7% | 519,195 | -31.7% | 0.00% | – |
| Q2 2023 | $1,870,816 | +2.0% | 760,494 | -6.3% | 0.00% | – |
| Q1 2023 | $1,834,742 | -13.4% | 811,833 | +33.8% | 0.00% | – |
| Q4 2022 | $2,117,787 | -97.0% | 606,816 | -67.7% | 0.00% | -100.0% |
| Q3 2022 | $69,468,000 | +203.6% | 1,876,504 | +55.8% | 0.02% | +128.6% |
| Q2 2022 | $22,880,000 | -17.9% | 1,204,813 | +16.6% | 0.01% | +40.0% |
| Q1 2022 | $27,885,000 | +260.3% | 1,033,172 | +200.8% | 0.01% | +400.0% |
| Q4 2021 | $7,739,000 | -34.9% | 343,454 | -24.3% | 0.00% | -50.0% |
| Q3 2021 | $11,895,000 | -7.9% | 453,852 | +12.5% | 0.00% | -33.3% |
| Q2 2021 | $12,909,000 | +618.0% | 403,283 | +689.8% | 0.00% | – |
| Q1 2021 | $1,798,000 | +150.1% | 51,061 | +127.8% | 0.00% | – |
| Q4 2020 | $719,000 | -3.0% | 22,419 | +13.8% | 0.00% | – |
| Q3 2020 | $741,000 | -93.2% | 19,700 | -93.8% | 0.00% | -100.0% |
| Q1 2020 | $10,918,000 | +249.3% | 320,072 | +299.3% | 0.01% | +400.0% |
| Q4 2019 | $3,126,000 | – | 80,166 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |